Inactief instrument
Koers Tetraphase Pharmaceuticals, Inc.
Aandelen
US88165N2045
Farmaceutische producten
| Bedrijfsleider | Titel | Leeftijd | Van |
|---|---|---|---|
Pavel Raifeld
PSD | President | 42 | - |
Katherine Dorris
SEC | Bedrijfssecretaris | - | - |
Stephen Basso
TRE | Treasurer | 60 | - |
| Bestuurder | Titel | Leeftijd | Van |
|---|---|---|---|
Pavel Raifeld
BRD | Directeur/Bestuurslid | 42 | - |
| Datum | Insider | Type | Hoofdpost | Volume | % marktkap. | |
|---|---|---|---|---|---|---|
| 28/07/20 | Tender | Directeur juridische afdeling | 15.022 | 0,2068% | ||
| 28/07/20 | Koop | Onderneming | 3.737.360 | 51,4559% | ||
| 28/07/20 | Tender | Director | 15.703 | 0,2162% |
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Varia. 1j. | Varia. 3j. | Kap.($) | |
|---|---|---|---|---|---|---|
 | -.--% | -10,93% | - | - | 16,07 mln. | |
| -0,53% | -3,95% | +55,23% | +152,74% | 1.024 mld. | |
| +0,21% | -2,68% | +55,61% | +53,02% | 618 mld. | |
| -2,51% | -3,25% | +32,76% | +67,76% | 443 mld. | |
| +0,06% | -0,42% | +37,53% | +30,67% | 349 mld. | |
| -0,14% | -0,24% | +34,41% | +39,01% | 297 mld. | |
| -0,69% | -0,30% | +11,55% | +12,93% | 264 mld. | |
| -7,37% | -4,40% | -2,54% | -43,87% | 209 mld. | |
| -0,64% | +2,43% | +30,52% | +64,49% | 208 mld. | |
| -0,82% | +0,70% | +15,96% | +71,01% | 162 mld. | |
| Gemiddelde | -1,24% | -1,20% | +30,11% | +49,75% | 397,08 mld. | |
| Gewogen gemiddelde per kap. | -0,99% | -1,93% | +39,24% | +72,95% |
Werknemers
-
Sector
Farmaceutische producten
